BRAF V600E Mutation Positive Clinical Trials in Paris
2 recruitingParis, France
Showing 1–2 of 2 trials
Recruiting
Not Applicable
A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal Cancer
Metastatic Colorectal CancerBRAF V600E Mutation Positive
UNICANCER400 enrolled45 locationsNCT05639413
Recruiting
Phase 2
Encorafenib Plus Cetuximab in a Neoadjuvant Setting in Patients With BRAF Mutation Localised Colon or Upper Rectum Cancer
Colorectal, CancerBRAF V600E Mutation Positive
Federation Francophone de Cancerologie Digestive30 enrolled1 locationNCT05706779